XML 39 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Series E Cumulative Redeemable Preferred Stock
Preferred Stock
Series E Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series E Cumulative Redeemable Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series F Cumulative Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings
Cumulative dividends and distributions
Noncontrolling Interest in Consolidated Joint Venture
Total
Beginning Balance at Dec. 31, 2018 $ 115,000     $ 75,000     $ 2,282 $ 2,728,684 $ 1,182,722 $ (1,440,202) $ 47,685 $ 2,711,171
Beginning Balance (in shares) at Dec. 31, 2018 4,600,000     3,000,000     228,246,247          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               2,221       2,221
Issuance of restricted common stock, net             $ 4 (4,439)       (4,435)
Issuance of restricted common stock, net (in shares)             345,132          
Forfeiture of restricted common stock (in shares)             (3,932)          
Common stock distributions and distributions payable                   (11,429)   (11,429)
Preferred stock dividends and dividends payable   $ (1,998) $ (1,998)   $ (1,209) $ (1,209)            
Distributions to noncontrolling interest                     (1,950) (1,950)
Net (loss) income                 16,317   1,599 17,916
Ending Balance at Mar. 31, 2019 $ 115,000     $ 75,000     $ 2,286 2,726,466 1,199,039 (1,454,838) 47,334 2,710,287
Ending Balance (in shares) at Mar. 31, 2019 4,600,000     3,000,000     228,587,447          
Beginning Balance at Dec. 31, 2019 $ 115,000     $ 75,000     $ 2,249 2,683,913 1,318,455 (1,619,779) 46,233 2,621,071
Beginning Balance (in shares) at Dec. 31, 2019 4,600,000     3,000,000     224,855,351          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               2,324       2,324
Issuance of restricted common stock, net             $ 4 (3,996)       (3,992)
Issuance of restricted common stock, net (in shares)             456,219          
Forfeiture of restricted common stock (in shares)             (355)          
Common stock distributions and distributions payable                   (10,777)   (10,777)
Preferred stock dividends and dividends payable   $ (1,998) $ (1,998)   $ (1,209) $ (1,209)            
Distributions to noncontrolling interest                     (2,000) (2,000)
Repurchases of outstanding common stock             $ (98) (103,796)       (103,894)
Repurchases of outstanding common stock (in shares)             (9,770,081)          
Net (loss) income                 (162,061)   (458) (162,519)
Ending Balance at Mar. 31, 2020 $ 115,000     $ 75,000     $ 2,155 $ 2,578,445 $ 1,156,394 $ (1,633,763) $ 43,775 $ 2,337,006
Ending Balance (in shares) at Mar. 31, 2020 4,600,000     3,000,000     215,541,134